{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:26:34Z","timestamp":1773732394085,"version":"3.50.1"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001279","name":"Great Ormond Street Hospital Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.neuropharm.2019.107854","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T02:45:51Z","timestamp":1574045151000},"page":"107854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Why we urgently need improved seizure and epilepsy therapies for children and neonates"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2905-6839","authenticated-orcid":false,"given":"Ronit M.","family":"Pressler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lieven","family":"Lagae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.107854_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0883073810384263","article-title":"Levetiracetam for treatment of neonatal seizures","volume":"26","author":"Abend","year":"2011","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejpn.2019.05.002","article-title":"Role of observational studies in supporting extrapolation of efficacy data from adults to children with epilepsy - a systematic review of the literature using lacosamide as an example","volume":"23","author":"Arzimanoglou","year":"2019","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40272-018-0286-0","article-title":"A review of the new antiepileptic drugs for focal-onset seizures in pediatrics: role of extrapolation","volume":"20","author":"Arzimanoglou","year":"2018","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.neuropharm.2019.107854_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10072-017-3188-y","article-title":"Lennox-Gastaut syndrome: a comprehensive review","volume":"39","author":"Asadi-Pooya","year":"2018","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2019.107854_bib5","first-page":"1","author":"Auvin","year":"2019","journal-title":"Epilepsia open"},{"key":"10.1016\/j.neuropharm.2019.107854_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nbd.2016.03.007","article-title":"Current understanding and neurobiology of epileptic encephalopathies","volume":"92","author":"Auvin","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2019.107854_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.siny.2018.01.003","article-title":"Neonatal epilepsy genetics","volume":"23","author":"Axeen","year":"2018","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.neuropharm.2019.107854_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2007.04.003","article-title":"Neonatal seizures: multicenter variability in current treatment practices","volume":"37","author":"Bartha","year":"2007","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib9","first-page":"S403","article-title":"'Implementation of a neonatal neuro-critical care program (N-NCC): improved seizure detection and management in neonates with hypoxic ischemic encephalopathy (HIE)'","volume":"80","author":"Bashir","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.2003.tb07517.x","article-title":"'Antiepileptic drugs and apoptosis in the developing brain","volume":"993","author":"Bittigau","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2019.107854_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004218.pub2","article-title":"'Anticonvulsants for neonates with seizures","author":"Booth","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2019.107854_bib12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/01.WNL.0000106944.59990.E6","article-title":"Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study","volume":"62","author":"Boylan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.107854_bib13","doi-asserted-by":"crossref","first-page":"F165","DOI":"10.1136\/fn.86.3.F165","article-title":"'Phenobarbitone, neonatal seizures, and video-EEG'","volume":"86","author":"Boylan","year":"2002","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.neuropharm.2019.107854_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1528-1157.1995.tb00960.x","article-title":"'Spatial and temporal characteristics of neonatal seizures","volume":"36","author":"Bye","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2019.107854_bib15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/01.WNL.0000152891.58694.71","article-title":"Midazolam in neonatal seizures with no response to phenobarbital","volume":"64","author":"Castro Conde","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.107854_bib16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1528-1167.2012.03495.x","article-title":"Successful use of fenfluramine as an add-on treatment for Dravet syndrome","volume":"53","author":"Ceulemans","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2019.107854_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.siny.2018.01.004","article-title":"Neonatal epilepsies: clinical management","volume":"23","author":"Cornet","year":"2018","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.neuropharm.2019.107854_bib18","first-page":"142","article-title":"Topiramate for seizures in preterm infants and the development of necrotizing enterocolitis","author":"Courchia","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2019.107854_bib19","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2019.107854_bib20","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2019.107854_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149686","article-title":"Safety of levetiracetam in paediatrics: a systematic review","volume":"11","author":"Egunsola","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107854_bib22","article-title":"Epilepsy genetics: clinical impacts and biological insights","author":"Ellis","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/jpn.JPN_172_16","article-title":"'Levetiracetam in neonatal seizures as first-line treatment: a prospective study'","volume":"12","author":"Falsaperla","year":"2017","journal-title":"J. Pediatr. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107854_bib25","first-page":"1","article-title":"Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study","author":"Filippi","year":"2017","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.neuropharm.2019.107854_bib26","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s13311-019-00739-y","article-title":"Treatment responsiveness in KCNT1-related epilepsy","volume":"16","author":"Fitzgerald","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2019.107854_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00134-019-05552-x","article-title":"Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children","volume":"45","author":"French","year":"2019","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.neuropharm.2019.107854_bib28","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2019.107854_bib29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpeds.2016.03.035","article-title":"Contemporary profile of seizures in neonates: a prospective cohort study","volume":"174","author":"Glass","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.neuropharm.2019.107854_bib30","first-page":"S396","article-title":"Seizures among preterm neonates: a multicenter cohort study","volume":"80","author":"Glass","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s13312-019-1586-3","article-title":"Levetiracetam versus phenobarbitone in neonatal seizures - a randomized controlled trial","volume":"56","author":"Gowda","year":"2019","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.neuropharm.2019.107854_bib32","first-page":"669","article-title":"Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome","volume":"140","author":"Griffin","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2019.107854_bib33","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1177\/0883073816664670","article-title":"'Standardized treatment of neonatal status epilepticus improves outcome'","volume":"31","author":"Harris","year":"2016","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1651-2227.1988.tb10602.x","article-title":"Lidocaine for treatment of severe seizures in newborn infants. I. Clinical effects and cerebral electrical activity monitoring","volume":"77","author":"Hellstrom-Westas","year":"1988","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.neuropharm.2019.107854_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/bs.pbr.2016.03.011","article-title":"Antiepileptic drug treatment strategies in neonatal epilepsy","volume":"226","author":"Hernan","year":"2016","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107854_bib36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"Jozwiak","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00018-005-5348-0","article-title":"Antiepileptic drugs and the developing brain","volume":"63","author":"Kaindl","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2019.107854_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.siny.2017.12.004","article-title":"Epileptogenesis in neonatal brain","volume":"23","author":"Katsarou","year":"2018","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.neuropharm.2019.107854_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.2384","article-title":"Tackling epilepsy with high-definition precision medicine: a review","author":"Kearney","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","article-title":"'Therapeutics based on stop codon read through","volume":"15","author":"Keeling","year":"2014","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2019.107854_bib41","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s11064-017-2262-4","article-title":"Neurodevelopmental effects of antiepileptic drugs","volume":"42","author":"Kellogg","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2019.107854_bib42","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fnins.2019.00310","article-title":"'Off-Label use of bumetanide for brain disorders: an overview","volume":"13","author":"Kharod","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107854_bib43","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dmcn.13215","article-title":"Seizure burden and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy","volume":"58","author":"Kharoshankaya","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"issue":"Suppl. 5","key":"10.1016\/j.neuropharm.2019.107854_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1167.2007.01285.x","article-title":"Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain","volume":"48","author":"Kim","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2019.107854_bib45","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.pediatrneurol.2012.03.006","article-title":"'Topiramate use in the neonatal period","volume":"46","author":"Kundak","year":"2012","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s13760-016-0734-y","article-title":"The importance of assessing behaviour and cognition in antiepileptic drug trials in children and adolescents","volume":"117","author":"Lagae","year":"2017","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.neuropharm.2019.107854_bib47","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/epi.13914","article-title":"Reduced infancy and childhood epilepsy following hypothermia-treated neonatal encephalopathy","volume":"58","author":"Liu","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2019.107854_bib48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpeds.2017.03.004","article-title":"'Electrographic seizures during the early postnatal period in preterm infants'","volume":"187","author":"Lloyd","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.neuropharm.2019.107854_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/14767058.2014.986651","article-title":"The treatment of neonatal seizures: focus on Levetiracetam","volume":"29","author":"Loiacono","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.neuropharm.2019.107854_bib50","doi-asserted-by":"crossref","first-page":"F267","DOI":"10.1136\/archdischild-2011-300716","article-title":"Cooling and seizure burden in term neonates: an observational study","volume":"97","author":"Low","year":"2012","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.neuropharm.2019.107854_bib51","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/j.1528-1167.2009.02132.x","article-title":"Interobserver agreement in neonatal seizure identification","volume":"50","author":"Malone","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2019.107854_bib52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.siny.2018.01.001","article-title":"Electroencephalographic monitoring for seizure identification and prognosis in term neonates","volume":"23","author":"Massey","year":"2018","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.neuropharm.2019.107854_bib53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/WNP.0b013e3182872919","article-title":"'Continuous EEG monitoring in the neonatal intensive care unit'","volume":"30","author":"McCoy","year":"2013","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0037-1608653","article-title":"A systematic review of the efficacy of levetiracetam in neonatal seizures","volume":"49","author":"McHugh","year":"2018","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.neuropharm.2019.107854_bib55","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1474-4422(15)00250-1","article-title":"The genetic landscape of the epileptic encephalopathies of infancy and childhood","volume":"15","author":"McTague","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neurol.2016.02.005","article-title":"Severe neonatal seizures: from molecular diagnosis to precision therapy?","volume":"172","author":"Milh","year":"2016","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib57","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.58.4.542","article-title":"Seizure-associated brain injury in term newborns with perinatal asphyxia","volume":"58","author":"Miller","year":"2002","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2019.107854_bib58","first-page":"S46","article-title":"Neonatal seizures: problems in diagnosis and classification","volume":"28","author":"Mizrahi","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2019.107854_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8060788","article-title":"Early clinical predictors of autism spectrum disorder in infants with tuberous sclerosis complex: results from the EPISTOP study","volume":"8","author":"Moavero","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuropharm.2019.107854_bib60","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.braindev.2017.01.006","article-title":"'Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy","volume":"39","author":"Moavero","year":"2017","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuropharm.2019.107854_bib61","doi-asserted-by":"crossref","first-page":"F187","DOI":"10.1136\/adc.2005.086314","article-title":"Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures","volume":"93","author":"Murray","year":"2008","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.neuropharm.2019.107854_bib62","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e31820af91a","article-title":"'Video-EEG monitoring in newborns with hypoxic-ischemic encephalopathy treated with hypothermia","volume":"76","author":"Nash","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.107854_bib63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0035-1558969","article-title":"Use of levetiracetam in neonates in clinical practice: a retrospective study at a German university hospital","volume":"46","author":"Neininger","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.neuropharm.2019.107854_bib64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/epi4.12298","article-title":"Neonatal seizures: is there a relationship between ictal electroclinical features and etiology? A critical appraisal based on a systematic literature review","volume":"4","author":"Nunes","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.neuropharm.2019.107854_bib65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.seizure.2019.08.012","article-title":"The best evidence for progressive myoclonic epilepsy: a pathway to precision therapy","volume":"71","author":"Orsini","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2019.107854_bib66","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital compared with phenytoin for the treatment of neonatal seizures","volume":"341","author":"Painter","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2019.107854_bib67","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/brain\/awu042","article-title":"Seizure burden is independently associated with short term outcome in critically ill children","volume":"137","author":"Payne","year":"2014","journal-title":"Brain"},{"issue":"52","key":"10.1016\/j.neuropharm.2019.107854_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2019.05.031","article-title":"Neonatal seizures: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"37","author":"Pellegrin","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.neuropharm.2019.107854_bib69","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/WCO.0000000000000425","article-title":"'Outcomes following electrographic seizures and electrographic status epilepticus in the pediatric and neonatal ICUs","volume":"30","author":"Pinchefsky","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0035-1567873","article-title":"Neonatal seizures: a review of outcomes and outcome predictors","volume":"47","author":"Pisani","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.neuropharm.2019.107854_bib71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejpn.2014.10.001","article-title":"Epilepsy after neonatal seizures: literature review","volume":"19","author":"Pisani","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib72","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/epi.12984","article-title":"Early and effective treatment of KCNQ2 encephalopathy","volume":"56","author":"Pisano","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2019.107854_bib73","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","article-title":"Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial","volume":"14","author":"Pressler","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib74","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.seizure.2015.09.014","article-title":"Amplitude-integrated EEG for detection of neonatal seizures: a systematic review","volume":"33","author":"Rakshasbhuvankar","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2019.107854_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2010.10.003","article-title":"Levetiracetam: safety and efficacy in neonatal seizures","volume":"15","author":"Ramantani","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib76","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yebeh.2018.09.015","article-title":"A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic-ischemic encephalopathy","volume":"88","author":"Rao","year":"2018","journal-title":"Epilepsy Behav."},{"issue":"5","key":"10.1016\/j.neuropharm.2019.107854_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2018-315624","article-title":"Characterisation of neonatal seizures and their treatment using continuous EEG monitoring: a multicentre experience","volume":"104","author":"Rennie","year":"2019","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.neuropharm.2019.107854_bib78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-3476(99)70374-4","article-title":"'The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study","volume":"134","author":"Ronen","year":"1999","journal-title":"J. Pediatr."},{"key":"10.1016\/j.neuropharm.2019.107854_bib79","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0887-8994(02)00621-5","article-title":"Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use","volume":"28","author":"Scher","year":"2003","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib80","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/ene.13195","article-title":"Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients","volume":"24","author":"Schoonjans","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib81","doi-asserted-by":"crossref","first-page":"232","DOI":"10.17712\/nsj.2016.3.20150726","article-title":"Efficacy and safety of levetiracetam in the management of seizures in neonates","volume":"21","author":"Sedighi","year":"2016","journal-title":"Neurosciences"},{"key":"10.1016\/j.neuropharm.2019.107854_bib82","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0883073807299858","article-title":"'Comparison of continuous drip of midazolam or lidocaine in the treatment of intractable neonatal seizures'","volume":"22","author":"Shany","year":"2007","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib83","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1212\/WNL.0000000000004284","article-title":"Profile of neonatal epilepsies: characteristics of a prospective US cohort","volume":"89","author":"Shellhaas","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.107854_bib84","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/WNP.0b013e31823e96d7","article-title":"'The American clinical neurophysiology society's guideline on continuous electroencephalography monitoring in neonates'","volume":"28","author":"Shellhaas","year":"2011","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2008.04.008","article-title":"'Off-label use of antiepileptic drugs for the treatment of neonatal seizures","volume":"39","author":"Silverstein","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib86","article-title":"Epilepsy genetics and the precision medicine matrix","author":"Sisodiya","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib87","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0883073812470734","article-title":"'Pharmacological treatment of neonatal seizures: a systematic review","volume":"28","author":"Slaughter","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib88","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41390-018-0242-2","article-title":"Recommendations for the design of therapeutic trials for neonatal seizures","volume":"85","author":"Soul","year":"2019","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2019.107854_bib90","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-3777","article-title":"Treating EEG seizures in hypoxic ischemic encephalopathy: a randomized controlled trial","volume":"136","author":"Srinivasakumar","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2019.107854_bib91","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ana.21463","article-title":"Sedative and anticonvulsant drugs suppress postnatal neurogenesis","volume":"64","author":"Stefovska","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165693","article-title":"Treatment trials for neonatal seizures: the effect of design on sample size","volume":"11","author":"Stevenson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107854_bib93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1684\/epd.2017.0950","article-title":"'Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice","volume":"20","author":"Striano","year":"2018","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.neuropharm.2019.107854_bib94","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/epi4.12348","article-title":"Possible precision medicine implications from genetic testing using combined detection of sequence and intragenic copy number variants in a large cohort with childhood epilepsy","volume":"4","author":"Truty","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.neuropharm.2019.107854_bib95","first-page":"31","article-title":"'A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures","volume":"17","author":"Tulloch","year":"2012","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2019.107854_bib96","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/bcp.12467","article-title":"'Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct","volume":"79","author":"Turner","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107854_bib97","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addr.2013.11.003","article-title":"Risk assessment of neonatal excipient exposure: lessons from food safety and other areas","volume":"73","author":"Turner","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuropharm.2019.107854_bib98","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/pr.2016.119","article-title":"The International Neonatal Consortium: collaborating to advance regulatory science for neonates","volume":"80","author":"Turner","year":"2016","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2019.107854_bib99","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1542\/peds.2009-0136","article-title":"Effect of treatment of subclinical neonatal seizures detected with aEEG: randomized, controlled trial","volume":"125","author":"van Rooij","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2019.107854_bib100","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2008.01894.x","article-title":"'Bumetanide for neonatal seizures: based on evidence or enthusiasm?","volume":"50","author":"Vanhatalo","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2019.107854_bib101","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1651-2227.2009.01659.x","article-title":"Approach to seizures in the neonatal period: a European perspective","volume":"99","author":"Vento","year":"2010","journal-title":"Acta Paediatr. Int. J. Paediatr."},{"key":"10.1016\/j.neuropharm.2019.107854_bib102","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000478651","article-title":"A distinctive ictal amplitude-integrated electroencephalography pattern in newborns with neonatal epilepsy associated with KCNQ2 mutations","volume":"112","author":"Vilan","year":"2017","journal-title":"Neonatology"},{"key":"10.1016\/j.neuropharm.2019.107854_bib103","series-title":"Guidelines on Neonatal Seizures","article-title":"WHO guidelines approved by the guidelines review committee","author":"WHO","year":"2011"},{"key":"10.1016\/j.neuropharm.2019.107854_bib104","first-page":"543","article-title":"Neural and behavioral alterations after early exposure to phenobarbital","volume":"10","author":"Yanai","year":"1989","journal-title":"Neurotoxicology (Little Rock)"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819304204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819304204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:05:47Z","timestamp":1758438347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819304204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":102,"alternative-id":["S0028390819304204"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107854","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why we urgently need improved seizure and epilepsy therapies for children and neonates","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107854"}}